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Perinatal Asphyxia (PA) represents an important cause of severe neurological deficits
including delayed mental and motor development, epilepsy, major cognitive deficits and
blindness. The interaction between neurons, astrocytes and endothelial cells plays a
central role coupling energy supply with changes in neuronal activity. Traditionally,
experimental research focused on neurons, whereas astrocytes have been more related
to the damage mechanisms of PA. Astrocytes carry out a number of functions that
are critical to normal nervous system function, including uptake of neurotransmitters,
regulation of pH and ion concentrations, and metabolic support for neurons. In this
work, we aim to review metabolic neuron-astrocyte interactions with the purpose
of encourage further research in this area in the context of PA, which is highly
complex and its mechanisms and pathways have not been fully elucidated to
this day.
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INTRODUCTION
Hypoxia-Ischemia (HI) in the human newborn, also called hypoxic-ischemic encephalopathy
or perinatal asphyxia (PA) is the interruption of gas exchange and blood flow to the fetus in
the perinatal period (Volpe, 2001) and remains a serious complication with a high mortality
and morbidity rate (van Bel and Groenendaal, 2008). It is usually caused by intrauterine
asphyxia—antepartum or intrapartum, and it derives in a great range of non-progressive
neurological deficits (Volpe, 1976). During the first days, the encephalopathy caused by
neonatal brain injury, is manifested by signs evolving from lethargy to hyper-excitability to
stupor (Sarnat and Sarnat, 1976). As a consequence of PA approximately 45% of newborn
die and 25% have permanent neurological deficits, including developmental delay, various
motor deficits—often clustered as ‘‘cerebral palsy’’—with or without mental retardation
(Vannucci and Perlman, 1997), learning deficits or disabilities (Gunn, 2000), visual and
hearing problems (Osborne et al., 2004), and various issues regarding school readiness
(Shankaran, 2009; Romero et al., 2014). Despite the great advances made in obstetric and
neonatal care during the last decades no effective treatment for PA brain injury has been developed.
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Although an adult brain is composed by approximately
100,000 million neurons, astrocytes—a non-excitable type of
cell—outnumber them by over fivefold, thus representing the
most numerous cell type within the whole central nervous system
(CNS) (Kandel, 1970). Over the past century, since Ramón
y Cajal’s histological studies took place and until nowadays,
neurons have been considered the morphological and functional
unit of the CNS (García-Marín et al., 2007; Navarrete and
Araque, 2014). For over a century astrocytes were given a passive
role in the CNS in which their function was regarded mainly
as support for neurons. It was only after electron microscopy
advances, when studies were focused in the morphology of
synapses, that their crucial role in the CNS was discovered.
Critical functions essential for the neuron to normally function,
were finally acknowledged (Markiewicz and Lukomska, 2006;
Kimelberg and Nedergaard, 2010).
Not many decades ago it was discovered that astrocytes not
only represent the main source of nutrients and growth factors
for neurons, but that they have a strategic localization that
enables intimate communication between them and neurons
(Halassa et al., 2007; Fiacco et al., 2009). This relationship is
based not only in physical proximity, but also in a highly complex
and fast intra and intercellular signaling system. Both cell types
are in continuous collaboration and these signaling pathways
make possible the intimate communication astrocytes share with
neurons that allows them to perform many critical functions
(Kirchhoff et al., 2001). An exhaustive metabolic exchange
occurs between these type of cells, for example astrocytes
express enzymes involved in several metabolic pathways that
neurons cannot express (Kirchhoff et al., 2001; Volpe, 2001).
Gap junction channels allow both types of brain cells to form
a large syncytium where astrocytes release several neuroactive
substances (Piet et al., 2004). Astrocytes also have a large amount
of neuro-transmitter receptors that allow them to maintain a
fluid communication with neurons (Sattler and Rothstein, 2006;
Seifert et al., 2006).
The normal function of this interaction in healthy conditions
promotes a constant and dynamic communication between
neurons and astrocytes, enabling them to influence and affect
each other in many ways. In this sense, understanding the
damage mechanisms of hypoxia, taking both cellular types
separately, results inconceivable. Along these lines, during
disease, this fluid communication can translate either in
cooperation in order to restore homeostasis, or the propagation
of damage (Hatten et al., 1991; Chen and Swanson, 2003;
Ferriero, 2004; Floyd and Lyeth, 2007; Jeong et al., 2014; Romero
et al., 2014). It has been shown that most of the injury in
the neonatal brain caused by PA is mainly due to a metabolic
imbalance (Ferriero, 2004). The role of astrocytes and their
symbiotic interaction with neurons is to create a metabolic
unit essential in the course of the injury. Taking into account
this relationship, but specially the role of astrocytes seems to
be crucial, not only to understand the several mechanisms
underlying the damage caused by PA, but also to develop
therapeutic tools to counteract the aforementioned devastating
consequences. Indeed, astrocytes appear to be more resistant
to damage than the rest of the cells present in the CNS and
several studies even suggest that they play a beneficial and
essential role when brain insult occurs (Desagher et al., 1996;
Blanc et al., 1998; Ye and Sontheimer, 1999; Ahlemeyer et al.,
2000).
In this article, we will summarize the mechanisms underlying
the damage caused by PA, as well as recent advances in
the knowledge gained about the crucial role of astrocytes
in their relationship with neurons. We will also revise
metabolic neuron-astrocyte interactions and their role in
PA brain injury in order to promote further understanding
of these processes as well as considering this neuron-
astrocyte relationship when developing neuroprotective tools
to counteract the devastating consequences that PA causes in
children.
PERINATAL ASPHYXIA: AN INJURY IN THE
IMMATURE BRAIN
The latest advances in the study of brain injury in neonates
during the past decades seem to confirm how erroneous it is
to conceive brain injury as a uniform event. On the contrary,
several recent studies have shown that neonatal brain injury is
not a consequence of a the primary insult due to PA, it has
been revealed that the cause is protean, and mainly metabolic, in
terms of energy failure during the re-oxygenation and transient
ischemia-reperfusion, but also that the brain injury caused by
PA can be due to defects in inherited metabolic pathways
(Ferriero, 2004). Several studies have shown that the mechanisms
underlying the pathogenesis of the HI injury are rather complex
in the immature brain and they are determined by many
variables, such as maturity level of the brain, timing and intensity
of asphyxia, selective vulnerability of the various regions in the
brain, the severity of the insult, and as aforesaid, the evolution
of the re-oxygenation phase (Walton et al., 1999; Ferriero, 2004;
Sugawara et al., 2004; Alvarez-Díaz et al., 2007; Romero et al.,
2015).
Throughout the mammalian clade, the brain requires a
permanent supply of oxygen and nutrients, especially during
development, when the brain needs large amounts of energy
(Chugani and Phelps, 1986; Takahashi et al., 1999). In the
adult brain, glucose is almost mandatory as an energy substrate,
whereas oxidative metabolism of glucose is also the most
efficient pathway during development; the immature brain has
the capacity to utilize other substrates, including ketone bodies,
lactate, fatty acids and amino acids for energy and biosynthesis
of lipids and proteins (Nehlig, 1997, 2004; Chowdhury et al.,
2007; Brekke et al., 2015). The substrates required to obtain
energy are transported via blood flow (Settergren et al., 1976).
But when PA occurs, energy levels fall immediately due to
deprivation of glucose and oxygen, and this constitutes an
hypoxic-ischemic event that affects brain maturation with long-
lasting consequences for the adult brain (Vannucci and Hagberg,
2004).
When a hypoxic-ischemic insult occurs, a mechanism of
neuronal injury known as excitotoxicity is unchained. Neuronal
glutamate (Glu) metabolism, which consists in the cycle of Glu
release, reuptake and re-synthesis, is the main metabolic pathway
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in the brain and it is coupled to cerebral glucose oxidation
(Sibson et al., 1998a,b). Removal of Glu from the extracellular
space depends on glial cells. Astrocytes cannot re-uptake the
Glu due to the lack of ATP, leading to high synaptic Glu
levels (Magistretti et al., 1999). During ischemia the intracellular
calcium levels present a significant rise, these high abnormal
concentrations activate calcium dependent proteases, lipases and
DNAses. Due to the lack of energy, the cell cannot perform the
synthesis of the previously damaged constituents (Doyle et al.,
2008).
A primary cell death is produced by glucose and oxygen
deprivation, paving the way for a more devastating secondary
cell loss due to reperfusion and re-oxygenation (Inder and
Volpe, 2000). In normally functioning mitochondria, more than
80% of oxygen in the cell is reduced to energy equivalents
(ATP) by cytochrome oxidase but the rest is converted to
superoxide anions. These anions will be reduced to water
by enzymatic and non-enzymatic antioxidant mechanisms in
normal conditions. In a hypoxic-ischemic event a damage to
the energy-producing machinery of the mitochondria is created,
the result is an accumulation of superoxide and a conversion
of superoxide to other reactive species such as the hydroxyl
radical (Capani et al., 2001, 2003; Ferriero, 2001). When re-
oxygenation occurs, the cells have been damaged by hypoxia,
mitochondrial oxidative phosphorylation is overwhelmed and
reactive oxygen species (ROS) accumulate (Ferriero, 2001). The
membrane and pump function are altered as a consequence of
free radicals’ accumulation, allowing more Glu release leading
to more excitotoxicity. In addition, the accumulation of free
radicals produces activation of pro-apoptotic mediators, and
direct DNA and protein damage. Several antioxidant enzymes,
superoxide dismutase, catalase, and glutathione peroxidase are
part of the antioxidant defense system. In the immature
brain of rats, these enzymes, display less activity compared
to the adult brain, this may reinforce the vulnerability of




As stated above, astrocytes, the main glial cell type found
in the CNS, generally outnumber neurons by over fivefold
(Sofroniew and Vinters, 2010). During the last five decades
astrocytes have been classified into two major categories,
depending on their morphology and spatial organization: fibrous
and protoplasmic (Haycock and Bro, 1975). Fibrous astrocytes,
are found in white matter and compared with protoplasmic
astrocytes, they have fewer but longer and larger unbranched
processes that contact nodes of Ranvier (Haycock and Bro, 1975).
Protoplasmatic astrocytes, present in gray matter, have shorter
and numerous processes in a uniform globoid distribution,
enveloping synapses (Haycock and Bro, 1975). Both types
of astrocytes form gap junctions between distal processes of
adjacent astrocytes, this is a specialized contact that allows the
direct transfer of small molecular weight molecules between
them (Peters, 2007). The traditional categorization also includes
another type of astrocytes known as radial astrocytes. Unlike
neurogenesis, gliogenesis remains active after birth in rats
and radial glia that are precursors of the astroglial linage
and are oriented at right angles to the ventricular surfaces and
have elongated and unbranched processes (Malatesta et al.,
2008). After neonatal HI, these cells present an abnormal
morphology and architecture, and it has been found that they
rapidly transform into astrocytes right after the insult and
over several weeks in the cortex of rats (Sizonenko et al.,
2008).
Certain proteins, such as glial fibrillary acidic protein (GFAP),
Glutamine Synthetase (GS) and S100β, expressed by astrocytes
are used as markers for immunohistochemical identification
of this cell type (Norenberg, 1979; Goldman, 2003; Gonçalves
et al., 2008). GFAP, a member of an intermediate filament
protein family, is involved in maintenance of white matter in
the CNS as well as in the integrity of the blood brain barrier
(BBB) (Liedtke et al., 1996; Kakinuma et al., 1998). Although
both types of astrocytes express GFAP, protoplasmic astroglia
does not express enough protein to stain positive with routine
immunohistochemical methods (Walz, 2000a,b). In previous
studies using transgenic mice, this protein has been proven
to be essential for the process of reactive astrogliosis and
glial scar formation while it seems to play no part in normal
morphology and function of most astrocytes in healthy CNS
(Pekny et al., 1995; Herrmann et al., 2008). During astrogliosis,
which occurs subsequently to trauma, astrocytes proliferate,
swell, and undertake fibrosis by the accumulation of filaments,
expressed as an increase in GFAP and/or the novo expression of
vimentin, the latter being the main feature of this process (Bauer
et al., 2007). Furthermore, S100β, leaks from astrocytes into
the blood after acute hypoxemia in the case of BBB disruption
(Giussani et al., 2005). Thereby, increased plasma levels of this
protein are considered as a good marker for different brain
injuries (Persson et al., 1987; Blennow et al., 2001). After leakage,
cells do not increase its expression, suggesting a reduction of
S-100 in brain cells (Goni-de-Cerio et al., 2009).
ANATOMICAL ORGANIZATION
In the CNS, there are no regions bare of astrocytes. The
distribution of this type of cells is orderly and well organized
in a contiguous and essentially non-overlapping manner.
Some anatomical studies have demonstrated that individual
protoplasmatic astrocytes in gray matter have non-overlapping
domains in the healthy CNS (Bushong et al., 2002; Ogata and
Kosaka, 2002; Halassa et al., 2007). Thus, only the most distal
tips of processes from individual astrocytes interlace with one
another where the gap junctions are formed. The diffusion of
molecules among them increase the communication between
adjacent astrocytes (Bushong et al., 2002, 2004; Ogata and
Kosaka, 2002; Nedergaard et al., 2003; Halassa et al., 2007).
Studies in cortical and hippocampus astrocytes showed that
these cells do not have overlapping territories and that a single
astrocyte process enwraps from four to eight neuronal somata,
hundreds of dendrites and enfold more than 100,000 synapses
(Bushong et al., 2002; Ogata and Kosaka, 2002; Halassa et al.,
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2007). Therefore, small bunches of neurons could be coordinated
by one astrocyte that contacts them to their somata. In contrast,
when an astrocyte transmits signals to dendrites or synapses
it regulates hundreds of neurons which somata are away from
each other, this is why astrocytes play a decisive role in
neural circuit tasks, in synaptic transmission and information
processing (Bushong et al., 2002; Halassa et al., 2007). This tight
relationship between neurons and astrocytes is bidirectional; in
fact it has been shown that alterations in gap junctions due to
connexins 43 and 30 cause demyelinization in neurons (Lutz
et al., 2009).
ASTROCYTES’ MAIN FUNCTIONS AND
THEIR INTIMATE INTERACTION WITH
NEURONS IN THE IMMATURE BRAIN
Development: Cell Migration, Synapses
Development and Pruning
During development, astrocytes act as a guide and support
for post-mitotic neuron migration. Radial glia express certain
receptors, as metabotropic Glu receptor 5, that play a key
role in promoting the extension of these cell processes, thus
regulating themigration of cortical neurons during development.
Moreover, the activation of this receptor promotes the survival
and proliferation of progenitor cells (Jansson and Åkerman,
2014). Although astrocytes have a close relationship with
neurons during development, guiding and controlling neuronal
networks, they also play a key role in biochemical regulation
of the development and growth of axons and dendrites.
They form molecular boundaries that play an important role
in axon growth and dendrites (Powell and Geller, 1999).
Growing axons are guided towards their target by molecules,
like some proteoglycans and the glycoprotein tenascin C,
which are, in fact, derived from astrocytes (Powell and Geller,
1999).
In the adult brain, astrocytes have the same function when
it comes to axonal regeneration and synaptogenesis. Indeed, a
study with ganglionic cells from the retina, demonstrated that in
the absence of glia, neurons showed poor synaptic activity, but
in presence of astrocytes, and not other cell types, it increased
at least 100 times (Pfrieger and Barres, 1997; Ullian et al.,
2001). It is worth to mention that another study showed a rise
in the amount of synapsis by 7 times when ganglionic cells
were co-cultured with astrocytes; this may explain the astrocyte-
mediated increase of synaptic activity (Ullian et al., 2001). This
increase is mediated by the correct release of thrombospondins,
a family of proteins expressed by astrocytes during development,
but also as a consequence of brain damage later in life, which
are responsible for synaptogenesis and are involved in correct
synapse functioning and development (Christopherson et al.,
2005).
Astrocytes also release specific signals involved in synaptic
pruning related to the development and function of synapses
(Barres, 2008). For example, astrocytes are responsible
for inducing C1q expression in synapses to tag them for
microglial removal at developmental stages (Stevens et al.,
2007). The involvement of astrocytes in synaptic pruning is
also mediated by the phagocytic pathway Draper/Megf10 and
Merk/integrinalpha(v)beta5 (Barres, 2008).
Tripartite Synapses
One of the most notorious advances regarding the knowledge
about astrocyte functions led to the concept of the tripartite
synapsis, developed as a consequence of the finding that,
not only their excitability, based in variations in intracellular
Ca2+ concentrations, can be regulated by neurons with
certain neurotransmitters release (Cornell-Bell and Finkbeiner,
1991), but also that neurons’ synapsis transmission can
be regulated, as well, by Glu released from astrocytes in
a Ca2+ dependent manner (Araque et al., 1999; Rusakov
et al., 2011; Nedergaard and Verkhratsky, 2012). From a
morphological point of view, astrocytes and neurons are
strategically placed as a unit in the synapses, in order to
maintain a close interaction, since both pre- and post-synaptic
zones are in close contact with astrocytic foot processes, which
suggests that astrocytes might be contributing to information
processing in neurons (Araque et al., 1999; Halassa et al.,
2007).
An increase in astrocytic cytosolic Ca2+ occurs as a
consequence of neuronal activity. There are two different types
of Ca2+ signaling modalities: oscillations and propagating waves
of this divalent cation (Cornell-Bell and Finkbeiner, 1991). Ca2+
oscillations are augments of the intracellular concentrations
of this ion limited to a single cell, provoked by exposure to
different transmitters, such as ATP, Glu and GABA (Charles
et al., 1991). They can also be triggered by extracellular Ca2+
removal. Propagating Ca2+ waves can be boosted by application
of focal electrical or mechanical stimulation (Charles et al.,
1991).
The other, Ca2+ signaling modality is propagating Ca2+
waves. This can be stimulated by local application of transmitters
such ATP or Glu, lowering extracellular Ca2+ levels, focal
electrical or mechanical stimulation. Astrocytic Ca2+ waves
are induced by elevated neuronal spiking frequency. This
was shown in anaesthetized rodents exposed to subsequent
sensory stimulation (Sanderson et al., 1990; Charles et al.,
1992). When astrocytes achieve a certain level of activation,
ATP will be released and it will provoke Ca2+ increases in
neighboring astrocytes, resulting in a spatial expansion of
astrocytic activation. This is why Ca2+ waves could be seen as
a means of astrocytic activation amplification.
To bear in mind the concept of tripartite synapses when
studying this interaction during PA becomes crucial, since
it was demonstrated that this relationship is characteristic of
the developmental period. Indeed, in astrocytes, the mGluR5,
which mediates the triggering of Ca2+ waves, is developmentally
regulated and peaks at postnatal day 7 in rodents (Araque et al.,
1999; Panatier et al., 2011). In fact, this receptor is the main
metabotropic Glu receptor and is expressed in progenitors and
radial glia cells (Di Giorgi Gerevini et al., 2004). Sun et al. (2013)
found no expression of mGluR5, in murine astrocytes after
postnatal day 3, and neither in human astrocytes from cortical
and hippocampal tissue in adults, suggesting that astrocytic Ca2+
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signaling evoked by synaptic release of Glu may thus be confined
to the young rodent pups. Also, the hippocampus, one of the
most vulnerable areas of the brain that suffers the consequences
of PA has at least 57% of the synapses has had astrocytic processes
opposed to them (Ventura and Harris, 1999).
As previously discussed, the conception of astrocytes as static
and isolated units has been cast down given a recent and
great body of evidence demonstrating how the highly dynamic
and complex interaction between neurons and astrocytes
contribute, not only to a healthy functioning of the CNS
under physiological conditions, but also, to survival and
resistance in pathophysiological circumstances. Their intimate
interactions range from the very development of the CNS, in
which their relationship makes possible cell migration, synapses
development and pruning, to the complex metabolic interaction
enabled by the strategic placement of both cell types.
Neurotransmission
In order to clear neurotransmitters from the synaptic space,
astrocytes express in their processes high levels of transporters
for neurotransmitters, such as Glu, GABA, and glycine (Sattler
and Rothstein, 2006; Seifert et al., 2006). Glu uptake is probably
the most important in this regard. After the release of Glu
from glutamatergic neurons, this compound must be inactivated
in order to avoid excitotoxicity. Whereas neurons also recycle
Glu via reuptake of this neurotransmitter, this process is a
pathway necessary for its reutilization (Hertz et al., 1999;
Daikhin and Yudkoff, 2000). This is accomplished through
cellular uptake of the neurotransmitter from the synapsis
(Clements et al., 1992), a task performed mostly by astrocytes
(Pellerin and Magistretti, 1994; Bergles and Jahr, 1998). A
synchronized de novo synthesis of amino acid transmitters
takes place in neurons, and astrocytes make the intermediator
available for this cycle to be accomplished. Their assistance
to neurons in this task results imperative, since Glutamine
Synthetase (GS), the enzyme responsible for Glu amidation into
glutamine, is present only in astrocytes and not in neurons
(Norenberg and Martinez-Hernandez, 1979). Glutamine has no
neurotransmission purpose so it can be safely released from
astrocytes for rapid neuronal uptake in order to complete
Glu regeneration in the neuron (Kvamme et al., 2000); (For
more information refer to ‘‘Glutamate Uptake by Astrocytes’’
Section).
This process leads to several changes in astrocyte metabolism,
due to the fact that Glu enters into astrocytes with co-
transportation of Na+, while K+ is extruded (Brew and Attwell,
1987), affecting astrocytic metabolism since intra-astrocytic Na+
concentrations increases and the Na+/K+ ATPase is activated.
The above mentioned processes result in further stimulation
of glycolysis and thus, glucose consumption that subsequently
generates lactate production (Chatton et al., 2000;Magistretti and
Pellerin, 2000).
Gliotransmition
It has been previously shown that astrocytes can exhibit
excitability due to neuronal or self-generated stimulation, and
thus are able to modulate synaptic transmission and excitability
(Araque et al., 2001; Volterra and Meldolesi, 2005; Harada
et al., 2015). Araque et al. (1998) demonstrated that when
an astrocyte is activated its intracellular Ca2+ levels rise,
as a result of Ca2+ release mainly from the endoplasmic
reticulum, causing the release of Glu and a delayed Ca2+
rise in nearby neurons. During the following decade different
components of this alleged exocytotic machinery in astrocytes
were discovered and identified, giving more strength to the
hypothesis of gliotransmission. Processes related to Ca2+
dependent release, a synaptic-like microvesicle (SLMV) which
is crucial for Glu release and exocytotic fusion were identified
over the years (Volterra and Meldolesi, 2005; Harada et al.,
2015).
Gliotransmission mechanisms have been proven to be quite
complex. For instance, it has been shown that different
stimuli that generate a Ca2+ dependent response, cause diverse
gliotransmitter release responses (Volterra and Meldolesi, 2005).
Moreover, non exocytotic gliotransmitters release has been
described. Indeed, gliotransmitters, particularly ATP and Glu,
can be released from volume regulated ion channels, gap-
junction hemmichanels and purinergic P2X receptors (Volterra
and Meldolesi, 2005).
Blood Brain Barrier
As previously mentioned, astrocytes play a key role in the
supply of certain metabolites that are essential for the developing
brain to function adequately, but this process starts with the
transport of these nutrients to the brain. An appropriate supply
of nutrients from circulation is assured by the BBB, which is
formed by various types of cells: pericytes, endothelial cells, basal
lamina and astrocytes (Engelhardt, 2003). All these cells are
arranged as a complex unit in charge of maintaining homeostasis
of low permeability thus supplying a wide range of nutrients
such as glucose, amino acids, monocarboxylates and vitamins,
essential for the proper development and functioning of the
brain (Møllgård and Saunders, 1986; Saunders et al., 1991, 2016).
This permeability depends mainly on a complexly specialized
endothelial cell layer of the brain whose phenotype differs
from the cells that form capillaries beyond the brain (Pries
et al., 2000). The essential role of astrocytes regarding metabolic
transport between the BBB and neurons lays in their close contact
with brain capillaries and endothelial cells, since this is what
allows them to be in direct contact with energy substrates and
metabolites that are transported from the blood to brain cells.
During development, radial glia participates in the expression
of proteins that form the tight junctions of microvessels.
Astrocytes end-feet inductive influence is also essential for the
complex tight junctions that make possible the specialization of
BBB endothelium phenotype (Janzer and Raff, 1987).
Astrocytes also play a key role in water homeostasis, their
processes count with a large amount of aquaporin water channels
(Zador et al., 2009) densely clustered, making contact with blood
vessels, and maintaining fluid homeostasis. Hence, when an
ischemic injury occurs, they play a strategic role regarding water
imbalance, brain swelling and thus, the progress of edema itself
(Kimelberg, 2005).
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Blood Vessels and Blood Flow
One of the hallmarks of brain energy metabolism is the
neurovascular coupling. A great body of evidence supports
the relationship between a local neuronal activation and the
ensuing changes in local blood flow in the brain, implicating
a wide variety of vasoactive agents such as H+, K+, several
neurotransmitters, adenosine, arachidonic acid, metabolites and
nitric oxide (Gordon et al., 2008; Carmignoto and Gómez-
Gonzalo, 2010; Gómez-Gonzalo et al., 2010). Astrocytes are
strategically positioned to both, sense neuronal activity in
the synapse and, with their end-feet enwrapped in blood
vessels, adequately respond with the corresponding metabolic
supply. Several studies evidence the key role of astrocytes
in the changes of blood flow related to neuronal activity,
not only vasoconstriction but also vasodilation, and especially
through their interaction with neurons and Glu signaling
(Takano et al., 2006; Iadecola and Nedergaard, 2007; Koehler
et al., 2009; Attwell et al., 2010; Carmignoto and Gómez-
Gonzalo, 2010). Some of these studies also show the part
astrocytes take in these processes through the release of
molecular mediators—such as arachidonic acid, nitric oxide and
prostaglandins- that help regulate the blood flow in the CNS
by increasing or decreasing blood vessels diameter (Figure 1)
(Gordon et al., 2007; Iadecola and Nedergaard, 2007). It
has also been shown via fMRI that the proper function of
astrocytes is essential to respond to visual stimuli in the visual
cortex (Schummers et al., 2008; Wolf and Kirchhoff, 2008).
Astrocytes had been shown to play a great part in neurovascular
coupling as important intermediates in neuronal signaling
to blood vessels. Hence, regarding neurovascular coupling,
our understanding of astrocytes functions is challenging
neurocentric paradigms to integrate the dynamic cooperation
with neurons.
Ions and K+Uptake
It is well known that astrocytes Figure 1 play a key role
in maintaining homeostasis in the extracellular environment,
spatially buffering ions such as K+ (Leis et al., 2005). Astrocytes
processes are rich in transporters utilized for K+ uptake
(Simard and Nedergaard, 2004; Seifert et al., 2006). Under
normal circumstances, astrocytes are able to take up K+
from extracellular areas with high concentration of this ions
and redistribute it into their own cytoplasmic volume and
gap junction syncytium, in order to posteriorly release it in
regions with lower K+ concentrations. In this fashion, astrocytes
are in charge of maintaining homeostasis in extracellular
space through a ‘‘spatial buffering’’ of K+ (Leis et al.,
2005). Moreover, astrocytes are intimately involved in proton
shuttling, for this purpose they have Na+/H+ exchangers,
bicarbonate transporters, monocarboxylic acid transporters, and
the vacuolar-type proton ATPase in their membrane (Obara
et al., 2008). After ischemia, ATP is consumed within 2 min,
these lack of energy leads to the release of potassium into the
extracellular space and entry of sodium into cells which causing




In the feat of delivering sufficient energy to sustain the high
requirements of the brain, it becomes hard to conceive glucose
as the mandatory and single metabolic substrate. Indeed, ketone
bodies are essential during development and starvation (Nehlig,
2004; Magistretti, 2008). Glycogen, reserved in astrocytes, can
be used throughout periods of elevated neuronal activity and
hypoglycemia, and lactate when performing intense physical
activity (Jeppesen et al., 2009). Furthermore, different types of
cells, under different circumstances, can efficiently exploit other
substrates or glucose intermediates, such as lactate, pyruvate,
Glu or acetate (Zielke et al., 2009). Some of the aforementioned
substrates, such as glucose or some monocarboxylates, are
transported from circulation into the brain by proteins belonging
to two integral membrane protein families: (1) GLUTs, glucose
transporters and (2) MCTs, proton-coupled monocarboxylic
acid transporters (Dwyer et al., 2002; Vannucci and Vannucci,
1997) (Figure 1).
Nowadays the fact that astrocytes Figure 1 make crucial
contributions to the CNS metabolism has become common
knowledge. This type of cell is well positioned to take up
glucose from blood vessels and provide energy metabolites
to different neural elements in gray and white matter. Their
processes contact blood vessels, synapses, neuronal perikarya
and axons, at nodes of Ranvier (Sofroniew and Vinters, 2010).
Furthermore, astrocytes are main storage sites of glycogen
granules in the CNS (Figure 1) (Phelps, 1972). A profound
understanding of the many metabolic pathways in the brain
challenges the limitations of the neuron-centered point of view
of neuroenergetics and metabolism leading to the concept of
metabolic cooperation between these two types of cells.
Glucose
There are at least two different ways of obtaining glucose: (1) by
transportation from blood vessels entering into the astrocytes
through GLUT1 or into neurons through GLUT3 and (2) by
hydrolysis of glycogen, which is localized predominantly in
astrocytes (Chen and Swanson, 2003). In both cases, pyruvate
is acquired via glycolysis. The lactate dehydrogenase converts
pyruvate into lactate which is shuttled to neurons via MCT1
(Chen and Swanson, 2003). As shown in Figure 1 neurons can
uptake other metabolites also like alanine and α-ketoglutarate
from astrocytes (Chen and Swanson, 2003).
Astrocytes play an important role supplying energy substrates
to neurons, a wide range of metabolic intermediates formed
from glucose in the brain can subsequently be oxidized for
energy production and depend basically on oxygen (e.g., lactate,
pyruvate, Glu, or acetate). For that reason, during neonatal
HI the neuronal function cannot be sustained despite of
the increase of GLUTs overexpression observed in immature
rat brain in this pathological condition. (Vannucci et al.,
1998).
The expression of GLUT1 in the BBB and the enzymes of
the tricarboxylic acid cycle are higher in the adult brain than
in the developing brain because glucose is the almost exclusive
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FIGURE 1 | I. Overview of different substrates obtained from glucose: (A) Glucose is transported from capillaries through GLUT1 and (B) into the neuron via
GLUT3 or into the astrocytes through GLUT1. (C) In astrocytes glucose can also be obtained from glycogen reserves to then be transformed into pyruvate which
enters into the mitochondria where cellular respiration takes place. The neuron can utilize glucose from blood or lactate, (D) transported from the astrocytes to get
the pyruvate. (E) Neurons can also uptake other metabolites like alanine, oleic acid, ketone bodies and α-ketoglutarate from astrocytes. II. Regulation of the blood
flow through the release of molecular mediators by astrocytes (F). III. Ions and K+ Uptake. (G) In normal conditions, astrocytes are involved in “spatial buffering” of
K+ and proton shuttling, for this purpose they have Na+/H+ exchangers, bicarbonate transporters, monocarboxylic acid transporters, and the vacuolar-type proton
ATPase in their membrane. (H) After ischemia, lack of energy leads to the release of potassium into the extracellular space and entry of sodium into cells, this causes
neuronal plasma membrane depolarization. Abbreviations: ETS, Electron Transport System; a-KG, α-ketoglutarate; LAC, Lactate; Pyr, Pyruvate; TCAC, Tricarboxylic
acid cycle; LDH, Lactate Dehydrogenase; ALA, Alanine; GLC, Glucose; K+, potassium; Na+, sodium; H+, proton.
fuel in the adult brain but not in the immature brain (Vannucci
and Simpson, 2003). The expression of this transporter rises
abruptly in the second postnatal week in rats (Vannucci et al.,
1993).
Role of Lactate in Developing Brain
Lactate is a significant metabolic substrate for the brain.
Throughout adult life, and particularly during a starvation
situation, lactate is used as an energy source by brain cells.
Astrocytic glycogen is broken down and, in this way, lactate
is obtained (Figure 2). Lactate is an exchangeable substrate
among astrocytes and neurons that works maintaining energy
homeostasis in the CNS (Medina and Tabernero, 2005). During
the perinatal period, lactate plays a very important part, it is
the main substrate during brain development and all brain cell
types use it as a precursor of lipids and energy source. This
premise regarding lactate as the main source of energy for
neurons is the foundation for the ‘‘lactate shuttle hypothesis’’
that postulates the idea that glial cells, especially astrocytes,
transform glucose into lactate which is then transported into
the neurons to be their metabolic source (Pellerin et al.,
2007). Astrocytes use lactate and other metabolic substrates to
synthesize oleic acid—which is the only fatty acid synthesized
by these cells and acts as a neurotrophic factor (Figure 1)
(Tabernero et al., 2001; Rodríguez-Rodríguez et al., 2004).
Neurons and oligodendrocytes use it as an energy source and
as a precursor of lipids. Regarding oligodendrocytes, they use
oleic acid for myelin synthesis, while neurons use lactate as
energy source for differentiation and proliferation. In other
words, lactate is an essential substrate in the developing brain,
such as glucose is in the adult brain. It is worth to mention
that in the immature brain, compared to the adult one, lactate
transport across the BBB is higher because of the predominant
expression of MCTs (Cremer, 1982; Conn et al., 1983;
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FIGURE 2 | Glutamine-glutamate pathway in astrocytes and neurons;
Glutathione synthesis in astrocytes and neurons; lactate production
from malate in astrocytes. Abbreviations: Glu, Glutamate; Gln, Glutamine;
GS, Glutamine Synthetase; PAG, phosphate-activated glutaminase;
TCAC, tricarboxylic acid cycle; GSH, gluthation; Cys, Cysteine;
Gly, Glycine; GCL, glutamine Cys ligase; GSH-syn, GSH synthetase.
Pellerin et al., 1998b; Fayol et al., 2004). In the intrauterine
period lactate is transported to the fetus throughout placental
membranes. The transplacental supply of nutrients finishes with
a phase of postnatal starvation, which is the pre-suckling period
that is followed by a fat-rich diet adaptation. After delivery
an increase in fatty acid concentrations occurs, this is due to
triacylglycerol breakdown. In human newborns fatty acids are
obtained from white adipose tissue. In rats, because of the lack
of white adipose tissue at birth, they come from hydrolysis of
triacylglycerols from the mother’s milk. Nonetheless, in both
species, once lactation is active, fatty acids come from the
intestinal hydrolysis of milk triacylglycerols (Aw and Grigor,
1980). Despite the fact that there is a rapid exchange of oxygen
between maternal and fetal blood, the rate of oxygen usage in
the fetus is moderate when compared to the one measured in
the newborn during the neonatal period (Battaglia and Meschia,
1978; Girard et al., 1981). This boost in oxygen accessibility
may well trigger the use of lactate (Medina, 1985), thus starting
postnatal energy homeostasis. Later on, in the suckling period,
ketone bodies become the main fuel for the brain and lactate
is used as the major gluconeogenic substrate (Fernández and
Medina, 1986).
Astrocyte—Neuron Lactate Exchange
In astrocyte cultures it was observed that this type of cells
produce lactate from extracellular glucose (Walz and Mukerji,
1988). These results suggest that astrocytes may convert blood
glucose into lactate through glycolysis. In addition, synaptic
activity seems to regulate this process, astrocytic glycolysis is
modulated with lactate necessities of neurons (Bouzier-Sore
et al., 2002). Lactate can pass through the plasma membrane
and be accessible to neurons (Pellerin et al., 1998b). Then,
lactate is transported to the neuron cytoplasm by specific carriers
(Figure 2) (Dringen et al., 1993; Tildon et al., 1993; Debernardi
et al., 2003).
Throughout the postnatal period, glucose is scarce but,
as already stated, lactate is used by both neurons and
astrocytes to maintain brain development. Glucose remainders
are used by the brain cells for production of nicotinamide
adenine dinucleotide phosphate (NADPH) and glycerol-borne
phospholipids (Tabernero et al., 1996).
The astrocytic and neuronal ability to use lactate in order to
save glucose for those purposes that lactate itself cannot fulfill,
might be the reason why this molecule is used in hypoglycemia
periods (Schurr et al., 1988; Bock et al., 1993; Izumi et al., 1994).
Ketone Bodies
Originally, the liver was thought to be the major, if not the
only organ, capable of supplying the brain with ketone bodies
(e.g., 3-hydroxybutyrate and acetoacetate) from fatty acids,
but not many decades ago it was discovered the ketogenesis
capacity of astrocytes not only from fatty acids, but also from
leucine (Auestad et al., 1991; Bixel and Hamprecht, 1995).
Furthermore, both, astrocytes ketogenic system resemble ketone
bodies production by hepatocytes, indicating both cell types
share similar properties (Guzmán and Blázquez, 2001).
As well as lactate supply from astrocytes is enhanced in
situations of high oxidative metabolism requirements for the
neurons, such as synaptic activity (Wiesinger et al., 1997; Pellerin
et al., 1998a; Deitmer, 2000; Tsacopoulos, 2002), it has been
found that Glu can enhance ketogenesis in astrocytes via Glu
transporters (Guzmán and Blázquez, 2004).
Under hypoxic conditions, anaerobic metabolism is
stimulated in astrocytes and lactate production is enhanced
and this molecule accumulates (Dienel and Hertz, 2001). An
AMP- activated protein kinase (AMPK) is activated in astrocytes
in response to metabolic stress, which phosphorylates and
inactivates acetyl-CoA carboxylase, thereby decreasing malonyl-
CoA concentration (Blazquez et al., 1999). Therefore, carnitine
palmitoyltransferase I (CPT-I), a mitochondrial outer membrane
enzyme, is released from inhibition and can increase the supply
of fatty acid substrates and the later production of ketone bodies
from β-oxidation in the mitochondrial matrix which are shuttled
from astrocytes to neurons (Figure 1) (Guzmán and Blázquez,
2004). In neuron cultures, the 3-hydroxybutyrate was preferred
over lactate as energy substrate in hypoxic conditions (Blazquez
et al., 1999). There is a debate about if ketone bodies may replace
glucose as an energy substrate to preserve neuronal function and
its neuroprotective role in hypoglycemia or HI (Arakawa et al.,
1991; Izumi et al., 1998; Brown et al., 2001; Massieu et al., 2001;
Guzmán and Blázquez, 2004).
Glycogen
As previously stated, astrocytes are the main storage sites of
glycogen granules in the CNS and maximum accumulation
of this substrate occurs in areas of high synaptic density
(Phelps, 1972). The content of glycogen can be modulated by
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neurotransmitters (Brown and Ransom, 2007). The utilization
of this glycogen can maintain neuronal activity throughout
periods of elevated neuronal activity and hypoglycemia. Under
conditions of hypoglycemia, there is evidence that indicates that
astrocytic glycogen breaks down into lactate and is transferred
to neighboring neural elements where it is used aerobically as
a carbon source (Voutsinos-Porche et al., 2003; Brown et al.,
2004; Brown and Ransom, 2007; Pellerin et al., 2007; Suh
et al., 2007). Moreover, studies in which computer models
were used proposed that throughout high neuronal activity,
an impediment of neuronal glycolysis is caused because of
the inhibition of phosphofructokinase I, and as a consequence
lactate from astrocytes becomes the favored neuronal energy
substrate (Occhipinti et al., 2009).
Glutamate-Glutamine Cycle
For years, it has been generally accepted that neurons release
Glu that is taken up by astrocytes that convert it to Glutamine
(Gln) through the action of the GS. Gln is then taken up
by neurons where, by the action of the phosphate-activated
glutaminase (PAG), it is converted into Glu that can be used
to produce GABA through the action of the Glu decarboxylase
(Figure 2) (Westergaard et al., 1995; Hertz et al., 1999; Calvetti
and Somersalo, 2013).
Glu has different metabolic fates in astrocytes and neurons.
For instance this neurotransmitter can either be converted to
Gln or enter to the tricarboxylic acid cycle (TCAC) from which
the cell may obtain lactate from malate (Figure 2) (Westergaard
et al., 1995; McKenna, 2007). Glu/Gln metabolism is regulated
through different mechanisms that include the availability
and distribution of metabolite transporters and the quantity and
activity of different key enzymes (McKenna, 2007). However
the metabolic fate of Glu in astrocytes is mainly dependent
on its external milieu concentrations (Westergaard et al., 1995;
McKenna et al., 1996; McKenna, 2007). At low Glu extracellular
concentrations, this compound is converted to Gln that can be
used by neurons to replenish their Glu or GABA pools (Farinelli
and Nicklas, 1992), while at higher concentrations Glu enters to
the TCAC for lactate and aspartate formation (Sonnewald et al.,
1993; Westergaard et al., 1995; McKenna et al., 1996; McKenna,
2007) (Figure 2).
Glutamate Uptake by Astrocytes
When Glu is released from a neuron into the synapse its
action as a neurotransmitter is regulated via uptake systems
located in neurons and astrocytes (Drejer et al., 1982; Pellerin
and Magistretti, 1994; Hertz et al., 1999). After Glu is released
to the synaptic clefts, where it interacts with receptors in
the postsynaptic neurons, Glu is taken up by highly efficient
transporters present in surrounding cells, most of which are
astrocytes (Anderson and Swanson, 2000; Šerý et al., 2015). Glu is
mainly co-transported with three Na+ molecules into astrocytes,
with the exit of a K+ or an OH−. Glu is also transported
by a Na+ independent uptake mechanism which is generally
chloride-dependent and it is executed by glutamate/cystine
antiporters (Anderson and Swanson, 2000). Glu uptake by
astrocytes is carried out through several transporters known
as excitatory amino acid transporters (EAATs), among these
EAAT1/GLAST and EAAT2/GLT1 are particularly located near
glutamatergic synapses and reprensent the most abundant
type of EAATs (Gegelashvili and Schousboe, 1998; Anderson
and Swanson, 2000; Gadea and López-Colomé, 2001; Šerý
et al., 2015). These receptors transport Glu against a high
concentration gradient constantly taking Glu from the synapse.
This constant uptake in glutamatergic neurons is necessary, both
to finish the neurotransmitter effect that it produces in the
synapse and to maintain low Glu levels to prevent excitotoxicity
(Pellerin andMagistretti, 1994; Gadea and López-Colomé, 2001).
Despite being constant, Glu uptake can be regulated, through
modifications in transporter expression or by changes in these
transporters activity that is closely related to ion grandients
and membrane potential (Gegelashvili and Schousboe, 1998;
Anderson and Swanson, 2000).
Gluthation Related Redox Regulation
It is now common knowledge that the brain is the most
vulnerable organ to oxidative damage (Dringen et al., 2000;
Fernandez-Fernandez et al., 2012; Johnson et al., 2012; Maity-
Kumar et al., 2015). It has been demonstrated that astrocytes
play a key role in neuron antioxidant and energy metabolism,
being gluthation (GSH) a pivotal player in astrocytic antioxidant
defense (Fernandez-Fernandez et al., 2012; Dringen et al., 2000,
2014; Schreiner et al., 2015). GSH is known as the main cellular
reductant and antioxidant compound. This tripeptide is present
in high concentrations in cells and is essential in redox regulation
and thiol pool regulation, besides playing a critical role in cell
fate (Hiroi et al., 2005; Valko et al., 2007). GSH is metabolized in
astrocytes, as well as other cell types, to Glu, Cysteine and Glycine
through the action of the glutamine Cys ligase and the GSH
synthetase (See Figure 2) (Dringen et al., 2000).
GSH levels are comparatively higher in astrocytes than
neurons (Fernandez-Fernandez et al., 2012). Moreover, neurons
present a relatively low expression of antioxidant enzymes and
scavangers in general. Additionally, astrocytes are responsible
for supplying neurons with the necessary substrates, especially
Cysteine, to produce their own GSH (Sagara et al., 1993; Bolanos
et al., 1996; Dringen et al., 1999, 2014). Thus, astrocytes become
essential for ROS and reactive nitrogen species detoxification in
neurons and for the maintenance of the metabolic and redox
balance in these cells (Dringen, 2000; Fernandez-Fernandez et al.,
2012; Narasimhan et al., 2012; Dringen et al., 2014).
METABOLIC COLLABORATION BETWEEN
NEURONS AND ASTROCYTES AGAINST
ENERGY FAILURE DURING PA
Over the past 30 years the enormous range of functions
astrocytes display, which result indispensable in order
to maintain homeostasis in a healthy CNS, have been
described. Given their fundamental role under physiological
circumstances, the crucial contribution that they have in
pathological mechanisms of severe diseases becomes evident.
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Astrocytes have developed several mechanisms that are
crucial to overcome brain injury (Trendelenburg and Dirnagl,
2005).
When approaching the protective or destructive mechanisms
manifested as a consequence of PA in the brain into the frame of
astrocytic and neuronal interaction, many aspects must be taken
into account. First of all, we consider that the target organ of
study, the brain, is one of the most complex and multifaceted
organs. We also have to consider the singular gestational and
chronological age, and how it interacts with brain development.
Furthermore, it is important to bear in mind the complexity
of such an intricate stimulus as HI. This turns the task of
experimentally trying to dissect neuroprotective mechanisms
from the ones that result destructive very problematic, due
to the fact that they both coexist and comprehend evolving
processes.
Metabolic Pathogenesis of PA
There is great agreement about the pathogenic mechanisms of
PA. A massive body of evidence supports the neuropathology
of PA as a general decrement in glucose and oxygen supply
caused, most of the times, by hypoxia and ischemia during the
perinatal period (Lai et al., 2011). Hypoxia is characterized by
low oxygen supply into the tissues, especially the brain, and it
is defined as the threshold in which oxygen concentrations limit
normal cellular processes (Reyes et al., 2012). Ischemia, on the
other hand, comprises a restraint in blood supply to different
organs (Radulova and Slancheva, 2014). The brain injury as
consequence of a PA involves an evolving process that, from
a temporal point of view, is developed in two phases: the first
one is initiated by a lack in oxygen and glucose supply that
causes a primary energy failure (PEF), followed by a secondary
energy failure (SEF) caused by reperfusion (Vannucci et al.,
2004).
Primary Energy Failure
The brain depends on oxygen to maintain aerobic metabolism,
thus the reduction of oxygen supply makes the sustenance
of aerobic metabolism, including mitochondrial oxidative
metabolism, impossible. In fact, general mitochondrial
metabolism was found to be reduced as far as 6 h after the
HI insult (Morken et al., 2014a). As a consequence, oxidative
phosphorylation becomes precluded and so does the electron
transport chain, thus, a switch to anerobic metabolism takes
place. The glycolysis pathway is activated, reflected in an increase
in glucose transporters after HI, as a compensatory mechanism
(Vannucci et al., 1998). At first, this is favorable for adaptation
to oxygen deprivation, but eventually the consequences of this
poor energy production pathway become evident since poor
stores of glucose in brain tissue are unable to compensate
the general discontinuation of glucose delivery taking place
due to ischemia (Herrera-Marschitz et al., 2014; Morken
et al., 2014a). In the context of a hypoxia, anaerobic glucose
utilization derives in production of lactic acid (Hochachka
and Mommsen, 1983; Siesjö, 1984). It is well known that
lactate accumulation may cause acidosis, although it was
found in rat pups that acidosis occurs independent of lactate
concentrations (Vannucci, 1990; Welsh et al., 1990; Vannucci
et al., 1992).
Although there is evidence showing that astrocytes, compared
to neurons, are usually more resistant to ischemia and other
damaging factors (Lukaszevicz et al., 2002), cultures of cortical
astrocytes indicate that this type of cell is mainly vulnerable
to acidosis (Giffard et al., 1990, 2000). Even though anaerobic
glycolysis allows astrocyte survival, the increase of lactic
acid throughout hypoxia has a negative impact in astrocyte
metabolism. Under these circumstances, non-oxidative ATP
production in cultured astrocytes cannot be maintained because
the pH falls under 6.6 with serious and irreversible astrocytic
damage (Swanson et al., 1997).
Long lasting episodes of mild acidosis (pH 6.8) affect
astrocytes in culture, since they are more sensitive compared to
neurons (Giffard et al., 1990). This could be attributed to the fact
that astrocytes express a cotransporter of sodium bicarbonate
which, during acidosis, mediates a sodium current into the
astrocytes’ interior (Giffard et al., 2000).
Notwithstanding the evident detrimental consequences of
lactate accumulation due to anaerobic metabolism, it has been
shown that lactate serves as an alternative metabolic source for
neurons. Moreover, it has been hypothesized that lactate may be
the main substrate in the adult brain (Wyss et al., 2011) as well as
aforesaid, in the developing CNS. This premise regarding lactate
as the main source of energy for neurons is the foundation for
the aforementioned ‘‘lactate shuttle hypothesis’’ (Pellerin et al.,
2007). Moreover, in the context of ischemia, it has also been
found that lactate represents an important alternate substrate to
glucose (Young et al., 1991).
The effects of hypoxia imply a general depression of
metabolism, but especially oxygen-dependent ATP production
pathways, and thus, those pathways that depend on ATP
consumption (Wu, 2002). This primary decrease in high energy
phosphate levels provokes a failure in the ATP dependent
Na+/K+ pump that leads to an intracellular accumulation of
Na+, Ca2+ and water, leading to cytotoxic edema formation (Lai
et al., 2011). These events favor membrane depolarization and
an increased release of excitatory neurotransmitters, especially
Glu. Thus, astrocytes and their interaction with neurons play
an essential role in Glu clearance during excitotoxicity. Glu
reuptake is done in a steep concentration gradient (Ereci´nska
and Silver, 1990) and the amount of energy necessary to
achieve this end requires a large amount of ATP consumption
(Sibson et al., 1998a). As previously stated, acidosis affects
non-oxidative ATP production in astrocytes, and thus it has
consequences in carrying out normal Glu uptake, which is
essential, particularly during HI, due to the exacerbated Glu
release (Swanson et al., 1995). Indeed, astrocytic Glu uptake is
essential for neuronal survival under neurotoxic circumstances.
Vulnerability of neurons to Glu excitotoxicity is 100 times higher
in absence of astrocyte intimate interaction (Rosenberg et al.,
1989). Furthermore, an increase on glial transporters involved in
Glu removal in pre-synapsis was observed in rats subjected to HI
(Tao et al., 2001).
Excitotoxicity damage is also potentiated by various
consequences of the energy failure: a disruption of the
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glutamine-glutamate cycle (Hagberg et al., 1987; Minc-Golomb
et al., 1987; Choi et al., 1988; Danbolt, 2001) since ATP is the
source of energy for glial glutamate transport (Sibson et al.,
1998a), a net reduction in Glu reuptake by neurons from the
synapsis after HI in rat hippocampus (Jabaudon et al., 2000),
and finally Glu release from astrocytes, caused by elevation of
extracellular K+ levels, as well as neurons Glu efflux (Rossi et al.,
2000).
Since astrocytes, as well as neurons, fail to maintain Glu
uptake the glutamine-glutamate cycle is disrupted and both types
of cells release great amounts of the neurotransmitter, producing
a subsequent receptor overstimulation. There is evidence that
the immature brain is more susceptible to excitotoxicity than
the adult brain, in fact, large injections of definir NMDA into
rat brain structures result in more extensive cell loss in the
neonate compared with the adult brain (McDonald et al., 1988).
Moreover, a parallel between the sensitivity of the rat brain to
the HI damage and NMDA toxicity has been found (Ikonomidou
et al., 1989). This susceptibility might be associated to the
fact that NMDA receptors not only are overexpressed, up to
2 times more, in the developing brain compared to the adult
(McDonald et al., 1988; Tremblay et al., 1988), but also because
they express a heterogenic functional pattern in the perinatal
period that, given a excitatory stimuli, facilitates an extended
and also prominent Ca2+ influx (Danysz and Parsons, 1998).
Regarding Glu receptors, during the neonatal period they show
greater density and function ability (McLean et al., 2004). It has
also been evidenced that Glu receptors expresses peaks of affinity
in the perinatal period of guinea pig fetus (Mishra et al., 1982).
This overstimulation of excitatory receptors leads to an
increase in cytosolic Ca2+, and generation of ROS that results
in an excito-oxidative injury cascade, including activation of
phospholipase (Morken et al., 2014b). Many of these cascades
converge into an ultimate target: the mitochondria (Hagberg
et al., 2014) but ultimately lead to a massive and devastating
cell loss. As we have previously stated astrocytes play a key role
against a redox imbalance caused by a massive generation of ROS
while their interaction with neurons is crucial for the survival of
the latter during such an event (See ‘‘Gluthation Related Redox
Regulation’’ section).
The features of the immature brain regarding an
improvement of the excitatory system, potentiates excitotoxicity,
exacerbating the damaging effects of the primary energy
depletion.
PEF leads to an evolving and devastating collapse in the main
cell functions that might provoke its very death or set the stage to
SEF damage that will ultimately lead to massive cell loss.
Secondary Energy Failure
When re-oxygenation occurs it is accompanied by
its characteristic reperfusion injury, however without
re-oxygenation survival would result impossible. SEF progress
diverges across species and depends on the severity of the
insult and its nature. There is certain agreement that there can
be an early SEF between 8–16 h, or a late one (24–48 h after
re-oxygenation) (Lorek et al., 1994; Penrice et al., 1997; Vannucci
et al., 2004).
Glucose and oxygen deficiency that led to a primary cell
death is followed by a secondary cell loss (Inder and Volpe,
2000) as a consequence of re-oxygenation. Oxidative metabolism
in the mitochondria recommences and there is a transient
recovery to baseline energy levels, observed from 2 to 3 hours
after reperfusion. The micro-environment of the cells, already
damaged by hypoxia, is now overflowed by oxygen that
overwhelms mitochondrial oxidative phosphorylation capacity,
which results in an accumulation of ROS (Ferreiro et al.,
2001).
The mitochondria, while being a ROS massive producer,
also have a particular susceptibility to ROS damage (Capani
et al., 2001, 2003). These organelles are the primary target of
a redox imbalance (Hagberg et al., 2014), ROS damage results
in a long-lasting failure of this organelle that causes a second
decline in energy levels observed across the following 48 h after
the transient recovery (Lorek et al., 1994; Penrice et al., 1997;
Vannucci et al., 2004; Romero et al., 2015). This secondary ATP
depletion has been observed in both, human and animal studies
based on superior index format for ‘‘31’’ magnetic resonance
spectroscopy, that shows that after an early recovery interval,
consisting in a phosphorus spectra restitution upon resuscitation
from asphyxia, there is indeed a secondary decline in energy
status constituted by tissue depletion of phosphocreatine, ATP
or both compounds (Lorek et al., 1994; Penrice et al., 1997;
Azzopardi et al., 2012). These studies have shown that the
secondary failure in cerebral energy status after HI is a significant
contributor to the ultimate brain damage (Williams et al.,
1992). Moreover, survival duration of the animals under anoxic
circumstances in 7 day old rats shows an inverse correlation with
cerebral metabolic rates (Duffy et al., 1975). In spite of these
results, studies conducted by Vannucci et al. (2004) indicate that
SEF following HI is not the cause, but a consequence of ultimate
brain damage (Towfighi et al., 2004).
Furthermore, it has been postulated that the cause of
mitochondrial metabolic impairment may not be the lack of
oxygen per se, but other detrimental factors related to the excito-
oxidative cascade (Niatsetskaya et al., 2012; Hagberg et al.,
2014). Indeed, glutamatergic excitotoxicity ultimately leads to
neuronal death (Choi et al., 1988), being one of the major
causes of cellular loss as a result of neonatal HI (Johnston
et al., 2011). The aforementioned hypothesis was also confirmed
by Morken et al. (2014a) in a rat model of neonatal HI in
which they observed a decrease in mitochondrial metabolism in
neurons, long after complete reperfusion and the reestablishment
of oxygen delivery. Moreover, novel data from our laboratory
supported the idea of general alterations of the redox state.
Overexpression of thioredoxins 1 and glutaredoxins 2, which are
two major members of the thioredoxin family in SH-SY5Y line
culture subjected to hypoxia-reoxygenation showed to contribute
to neuronal integrity (Romero et al., 2015).
Taking these results into consideration, it seems fair to
conclude that there is a direct association between SEF and
delayed, irreversible metabolic crisis, whereas it remains unclear
if there is a parallelism between temporal evolution and cell death
and that these events are strongly tied to neuron and astrocytes
as well as their interactions.
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CONCLUSION
To our knowledge, the role of neuron-astrocyte interaction in
relation to PA has never been revised to the moment. Here we
have summarized many of the aspects that we think should be
taken into account when studying PA, along with the newest
advances in the field.
Given that the perinatal period is of particular importance
for the developing brain, taking into account the continuous
collaboration between astrocytes and neurons seems to be
essential when studying PA pathogenic mechanisms and effects
in the developing brain. As aforesaid, the intricate relationship
between these cell types plays a decisive role in the normal
functioning of the developing CNS. Besides the crucial part
they both play under healthy circumstances, there have been
also great advances in identifying how this interaction works
when brain insult occurs, influencing not only the development
of brain injury in the perinatal period, but also the recovery.
We have extensively revised several advantages that each cell
type has, compensating the disadvantages of the other one,
the molecular and signaling pathways that could be activated
under HI conditions and that enable crucial collaboration during
energy failure.
The aforementioned aspects in this work should be taken
into consideration in the development of future treatments
since most of the findings point towards astrocyte-neuron
metabolic interaction as potential therapeutic targets. These
findings should also stimulate further research to resolve and
confirm some of the discussions regarding topics such as the
actual contributions of SEF to ultimate cell loss, the critical role
of lactate and other substrates as alternative metabolic sources
or as decisive contributors to detrimental acidosis under PA,
and the role of mitochondrial dysfunction and its damaging
consequences over astrocyte normal functioning, especially
over glutamate-glutamine cycle that ultimate affects neuron
as well.
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